{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:09:17Z","timestamp":1779440957857,"version":"3.53.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41401-025-01735-z","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:49:36Z","timestamp":1771843776000},"page":"1488-1500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A modified tail suspension test for the assessment of behavioral despair in mice after stroke"],"prefix":"10.1038","volume":"47","author":[{"given":"Pei-ran","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-yin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-ya","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-xia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"1735_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBD 2019 Stroke Collaborators.","year":"2021","unstructured":"GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 2021;20:795\u2013820.","journal-title":"Lancet Neurol."},{"key":"1735_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jad.2023.10.037","volume":"344","author":"D Colita","year":"2024","unstructured":"Colita D, Burdusel D, Glavan D, Hermann DM, Colita CI, Colita E, et al. Molecular mechanisms underlying major depressive disorder and post-stroke affective disorders. J Affect Disord. 2024;344:149\u201358.","journal-title":"J Affect Disord"},{"key":"1735_CR3","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00415-021-10597-4","volume":"269","author":"J Guo","year":"2022","unstructured":"Guo J, Wang J, Sun W, Liu X. The advances of post-stroke depression: 2021 update. J Neurol. 2022;269:1236\u201349.","journal-title":"J Neurol"},{"key":"1735_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(14)70016-X","volume":"13","author":"ML Hackett","year":"2014","unstructured":"Hackett ML, Kohler S, O\u2019Brien JT, Mead GE. Neuropsychiatric outcomes of stroke. Lancet Neurol. 2014;13:525\u201334.","journal-title":"Lancet Neurol"},{"key":"1735_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/B978-0-12-822290-4.00007-4","volume":"183","author":"M Harciarek","year":"2021","unstructured":"Harciarek M, Mankowska A. Hemispheric stroke: mood disorders. Handb Clin Neurol. 2021;183:155\u201367.","journal-title":"Handb Clin Neurol"},{"key":"1735_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S2215-0366(16)30417-5","volume":"4","author":"JS Kim","year":"2017","unstructured":"Kim JS, Lee EJ, Chang DI, Park JH, Ahn SH, Cha JK, et al. Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study. Lancet Psychiatry. 2017;4:33\u201341.","journal-title":"Lancet Psychiatry"},{"key":"1735_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1474-4422(20)30207-6","volume":"19","author":"AFFINITY Trial Collaboration.","year":"2020","unstructured":"AFFINITY Trial Collaboration. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2020;19:651\u201360.","journal-title":"Lancet Neurol"},{"key":"1735_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1474-4422(20)30219-2","volume":"19","author":"EFFECTS Trial Collaboration.","year":"2020","unstructured":"EFFECTS Trial Collaboration. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2020;19:661\u20139.","journal-title":"Lancet Neurol"},{"key":"1735_CR9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S2215-0366(19)30292-5","volume":"6","author":"IA Cristea","year":"2019","unstructured":"Cristea IA, Naudet F. US food and drug administration approval of esketamine and brexanolone. Lancet Psychiatry. 2019;6:975\u20137.","journal-title":"Lancet Psychiatry"},{"key":"1735_CR10","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"GS Malhi","year":"2018","unstructured":"Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299\u2013312.","journal-title":"Lancet"},{"key":"1735_CR11","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455:894\u2013902.","journal-title":"Nature"},{"key":"1735_CR12","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41583-019-0221-6","volume":"20","author":"A Gururajan","year":"2019","unstructured":"Gururajan A, Reif A, Cryan JF, Slattery DA. The future of rodent models in depression research. Nat Rev Neurosci. 2019;20:686\u2013701.","journal-title":"Nat Rev Neurosci"},{"key":"1735_CR13","doi-asserted-by":"publisher","first-page":"14224","DOI":"10.1073\/pnas.1207461109","volume":"109","author":"Y Hu","year":"2012","unstructured":"Hu Y, Wu DL, Luo CX, Zhu LJ, Zhang J, Wu HY, et al. Hippocampal nitric oxide contributes to sex difference in affective behaviors. Proc Natl Acad Sci USA. 2012;109:14224\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1735_CR14","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.cell.2023.02.036","volume":"186","author":"HY Li","year":"2023","unstructured":"Li HY, Zhu MZ, Yuan XR, Guo ZX, Pan YD, Li YQ, et al. A thalamic-primary auditory cortex circuit mediates resilience to stress. Cell. 2023;186:1352\u201368.","journal-title":"Cell"},{"key":"1735_CR15","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1038\/s41380-020-0796-3","volume":"26","author":"S Pothula","year":"2021","unstructured":"Pothula S, Kato T, Liu RJ, Wu M, Gerhard D, Shinohara R, et al. Cell-type specific modulation of NMDA receptors triggers antidepressant actions. Mol Psychiatry. 2021;26:5097\u2013111.","journal-title":"Mol Psychiatry"},{"key":"1735_CR16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41586-023-06624-1","volume":"622","author":"S Ma","year":"2023","unstructured":"Ma S, Chen M, Jiang Y, Xiang X, Wang S, Wu Z, et al. Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb. Nature. 2023;622:802\u20139.","journal-title":"Nature"},{"key":"1735_CR17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.biopsych.2018.05.007","volume":"84","author":"C Yang","year":"2018","unstructured":"Yang C, Kobayashi S, Nakao K, Dong C, Han M, Qu Y, et al. AMPA receptor activation-independent antidepressant actions of ketamine metabolite (s)-norketamine. Biol Psychiatry. 2018;84:591\u2013600.","journal-title":"Biol Psychiatry"},{"key":"1735_CR18","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1523\/JNEUROSCI.0422-20.2021","volume":"41","author":"CY Yin","year":"2021","unstructured":"Yin CY, Huang SY, Gao L, Lin YH, Chang L, Wu HY, et al. Neuronal nitric oxide synthase in nucleus accumbens specifically mediates susceptibility to social defeat stress through cyclin-dependent kinase 5. J Neurosci. 2021;41:2523\u201339.","journal-title":"J Neurosci"},{"key":"1735_CR19","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1126\/science.abo3566","volume":"378","author":"N Sun","year":"2022","unstructured":"Sun N, Qin YJ, Xu C, Xia T, Du ZW, Zheng LP, et al. Design of fast-onset antidepressant by dissociating SERT from nNOS in the DRN. Science. 2022;378:390\u20138.","journal-title":"Science"},{"key":"1735_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48730-2","volume":"15","author":"F Guo","year":"2024","unstructured":"Guo F, Fan J, Liu JM, Kong PL, Ren J, Mo JW, et al. Astrocytic ALKBH5 in stress response contributes to depressive-like behaviors in mice. Nat Commun. 2024;15:4347.","journal-title":"Nat Commun"},{"key":"1735_CR21","first-page":"5","volume":"5","author":"V Castagne","year":"2010","unstructured":"Castagne V, Moser P, Roux S, Porsolt RD. Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Pharmacol. 2010;5:5\u20138.","journal-title":"Curr Protoc Pharmacol"},{"key":"1735_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 1977;266:730\u20132.","journal-title":"Nature"},{"key":"1735_CR23","doi-asserted-by":"publisher","first-page":"112047","DOI":"10.1016\/j.bbr.2019.112047","volume":"372","author":"G Unal","year":"2019","unstructured":"Unal G, Canbeyli R. Psychomotor retardation in depression: a critical measure of the forced swim test. Behav Brain Res. 2019;372:112047.","journal-title":"Behav Brain Res"},{"key":"1735_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3758\/s13415-024-01171-2","volume":"24","author":"S Gencturk","year":"2024","unstructured":"Gencturk S, Unal G. Rodent tests of depression and anxiety: construct validity and translational relevance. Cogn Affect Behav Neurosci. 2024;24:191\u2013224.","journal-title":"Cogn Affect Behav Neurosci"},{"key":"1735_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.biopsych.2012.02.026","volume":"72","author":"G Kronenberg","year":"2012","unstructured":"Kronenberg G, Balkaya M, Prinz V, Gertz K, Ji S, Kirste I, et al. Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression. Biol Psychiatry. 2012;72:273\u201381.","journal-title":"Biol Psychiatry"},{"key":"1735_CR26","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1111\/bph.12775","volume":"171","author":"G Kronenberg","year":"2014","unstructured":"Kronenberg G, Gertz K, Heinz A, Endres M. Of mice and men: modelling post-stroke depression experimentally. Br J Pharmacol. 2014;171:4673\u201389.","journal-title":"Br J Pharmacol"},{"key":"1735_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s13311-017-0590-3","volume":"15","author":"F Vahid-Ansari","year":"2018","unstructured":"Vahid-Ansari F, Albert PR. Chronic fluoxetine induces activity changes in recovery from poststroke anxiety, depression, and cognitive impairment. Neurotherapeutics. 2018;15:200\u201315.","journal-title":"Neurotherapeutics"},{"key":"1735_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/svn-2022-002156","volume":"8","author":"H Wu","year":"2023","unstructured":"Wu H, Huang Z, Wang X, Chen M, Chen W, Hua Y, et al. Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects. Stroke Vasc Neurol. 2023;8:463\u201374.","journal-title":"Stroke Vasc Neurol"},{"key":"1735_CR29","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1016\/j.apsb.2023.05.012","volume":"13","author":"S Xiong","year":"2023","unstructured":"Xiong S, Xiao H, Sun M, Liu Y, Gao L, Xu K, et al. Glutamate-releasing BEST1 channel is a new target for neuroprotection against ischemic stroke with wide time window. Acta Pharm Sin B. 2023;13:3008\u201326.","journal-title":"Acta Pharm Sin B"},{"key":"1735_CR30","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/nm.2245","volume":"16","author":"L Zhou","year":"2010","unstructured":"Zhou L, Li F, Xu HB, Luo CX, Wu HY, Zhu MM, et al. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat Med. 2010;16:1439\u201343.","journal-title":"Nat Med"},{"key":"1735_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.124","volume":"6","author":"F Vahid-Ansari","year":"2016","unstructured":"Vahid-Ansari F, Lagace DC, Albert PR. Persistent post-stroke depression in mice following unilateral medial prefrontal cortical stroke. Transl Psychiatry. 2016;6:e863.","journal-title":"Transl Psychiatry"},{"key":"1735_CR32","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","volume":"13","author":"MY Liu","year":"2018","unstructured":"Liu MY, Yin CY, Zhu LJ, Zhu XH, Xu C, Luo CX, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc. 2018;13:1686\u201398.","journal-title":"Nat Protoc"},{"key":"1735_CR33","doi-asserted-by":"publisher","first-page":"12258","DOI":"10.1523\/JNEUROSCI.0805-11.2011","volume":"31","author":"QG Zhou","year":"2011","unstructured":"Zhou QG, Hu Y, Wu DL, Zhu LJ, Chen C, Jin X, et al. Hippocampal telomerase is involved in the modulation of depressive behaviors. J Neurosci. 2011;31:12258\u201369.","journal-title":"J Neurosci"},{"key":"1735_CR34","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.7150\/thno.58364","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Zhang L, Xu C, Shen YY, Lin YH, Zhang Y, et al. A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and alpha2-containning GABA(a)rs. Theranostics. 2021;11:5970\u201385.","journal-title":"Theranostics"},{"key":"1735_CR35","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","volume":"21","author":"A Mathis","year":"2018","unstructured":"Mathis A, Mamidanna P, Cury KM, Abe T, Murthy VN, Mathis MW, et al. DeepLabCut: markerless pose estimation of user-defined body parts with deep learning. Nat Neurosci. 2018;21:1281\u20139.","journal-title":"Nat Neurosci"},{"key":"1735_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 2005;29:571\u2013625.","journal-title":"Neurosci Biobehav Rev"},{"key":"1735_CR37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl). 1985;85:367\u201370.","journal-title":"Psychopharmacology (Berl)"},{"key":"1735_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbi.2014.09.012","volume":"44","author":"R Duseja","year":"2015","unstructured":"Duseja R, Heir R, Lewitus GM, Altimimi HF, Stellwagen D. Astrocytic TNFalpha regulates the behavioral response to antidepressants. Brain Behav Immun. 2015;44:187\u201394.","journal-title":"Brain Behav Immun."},{"key":"1735_CR39","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1038\/s41380-020-00916-y","volume":"26","author":"MV Fogaca","year":"2021","unstructured":"Fogaca MV, Wu M, Li C, Li X, Picciotto MR, Duman RS. Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses. Mol Psychiatry. 2021;26:3277\u201391.","journal-title":"Mol Psychiatry"},{"key":"1735_CR40","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977;229:327\u201336.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"1735_CR41","doi-asserted-by":"crossref","unstructured":"Can A, Dao DT, Terrillion CE, Piantadosi SC, Bhat S, Gould TD The tail suspension test. J Vis Exp. 2012:e3769.","DOI":"10.3791\/3769-v"},{"key":"1735_CR42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/07853891003769957","volume":"42","author":"DD Pollak","year":"2010","unstructured":"Pollak DD, Rey CE, Monje FJ. Rodent models in depression research: classical strategies and new directions. Ann Med. 2010;42:252\u201364.","journal-title":"Ann Med"},{"key":"1735_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s002130100687","volume":"155","author":"AJ Mayorga","year":"2001","unstructured":"Mayorga AJ, Lucki I. Limitations on the use of the c57BL\/6 mouse in the tail suspension test. Psychopharmacology (Berl). 2001;155:110\u201312.","journal-title":"Psychopharmacology (Berl)"},{"key":"1735_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","volume":"6","author":"P Willner","year":"2017","unstructured":"Willner P. The chronic mild stress (CMS) model of depression: history, evaluation and usage. Neurobiol Stress. 2017;6:78\u201393.","journal-title":"Neurobiol Stress"},{"key":"1735_CR45","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci. 2010;13:1161\u20139.","journal-title":"Nat Neurosci"},{"key":"1735_CR46","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0006-3223(02)01405-1","volume":"52","author":"EJ Nestler","year":"2002","unstructured":"Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, Greshenfeld HK, et al. Preclinical models: status of basic research in depression. Biol Psychiatry. 2002;52:503\u201328.","journal-title":"Biol Psychiatry"},{"key":"1735_CR47","doi-asserted-by":"publisher","first-page":"104560","DOI":"10.1016\/j.neubiorev.2022.104560","volume":"135","author":"V Cnops","year":"2022","unstructured":"Cnops V, Iyer VR, Parathy N, Wong P, Dawe GSTest. rinse, repeat: a review of carryover effects in rodent behavioral assays. Neurosci Biobehav Rev. 2022;135:104560.","journal-title":"Neurosci Biobehav Rev"},{"key":"1735_CR48","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.biopsych.2017.06.008","volume":"82","author":"D Carlson","year":"2017","unstructured":"Carlson D, David LK, Gallagher NM, Vu MT, Shirley M, Hultman R, et al. Dynamically timed stimulation of corticolimbic circuitry activates a stress-compensatory pathway. Biol Psychiatry. 2017;82:904\u201313.","journal-title":"Biol Psychiatry"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01735-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01735-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01735-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:02:38Z","timestamp":1779440558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01735-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1735"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01735-z","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CXL, YHL, HYW, LC and PRK have submitted a patent application concerning the mTST described in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}